References
- Bulun SE. Endometriosis. N Engl J Med. 2009; 360:268–279.
- Giudice LC, Kao LC. Endometriosis. Lancet. 2004; 364:1789–1799.
- Fassbender A, Burney RO, O DF, et al. Update on biomarkers for the detection of endometriosis. Biomed Res Int. 2015;2015:130854.
- Bullon P, Navarro JM. Inflammasome as a key pathogenic mechanism in endometriosis. Curr Drug Targets. 2017; 18:997–1002.
- Falcone T, Flyckt R. Clinical management of endometriosis. Obstet Gynecol. 2018;131:557–571.
- Patel BG, Lenk EE, Lebovic DI, et al. Pathogenesis of endometriosis: Interaction between Endocrine and inflammatory pathways. Best Pract Res Clin Obstet Gynaecol. 2018;50:50–60.
- Urata Y, Koga K, Hirota Y, et al. IL-1beta increases expression of tryptophan 2,3-dioxygenase and stimulates tryptophan catabolism in endometrioma stromal cells. Am J Reprod Immunol. 2014;72:496–503.
- Mosbah A, Nabiel Y, Khashaba E. Interleukin-6, intracellular adhesion molecule-1, and glycodelin A levels in serum and peritoneal fluid as biomarkers for endometriosis. Int J Gynaecol Obstet 2016;134:247–251.
- Suen JL, Chang Y, Chiu PR, et al. Serum level of IL-10 is increased in patients with endometriosis, and IL-10 promotes the growth of lesions in a murine model. Am J Pathol. 2014;184:464–471.
- Jiang JF, Deng Y, Xue W, et al. Increased expression of interleukin 37 in the eutopic and ectopic endometrium of patients with ovarian endometriosis. Reprod Sci. 2016;23:244–248.
- Fassbender A, Vodolazkaia A, Saunders P, et al. Biomarkers of endometriosis. Fertil Steril. 2013;99:1135–1145.
- Riccio L, Santulli P, Marcellin L, et al. Immunology of endometriosis. Best Pract Res Clin Obstet Gynaecol. 2018;50:39–49.
- Ahn SH, Singh V, Tayade C. Biomarkers in endometriosis: challenges and opportunities. Fertil Steril. 2017;107:523–532.
- Lambert S, Santulli P, Chouzenoux S, et al. Endometriosis: increasing concentrations of serum interleukin-1beta and interleukin-1sRII is associated with the deep form of this pathology. J Gynecol Obstet Biol Reprod (Paris). 2014;43:735–743.
- Akoum A, Al-Akoum M, Lemay A, et al. Imbalance in the peritoneal levels of interleukin 1 and its decoy inhibitory receptor type II in endometriosis women with infertility and pelvic pain. Fertil Steril. 2008;89:1618–1624.
- Bedaiwy MA, Falcone T, Sharma RK, et al. Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial. Hum Reprod. 2002;17:426–431.
- Hassa H, Tanir HM, Tekin B, et al. Cytokine and immune cell levels in peritoneal fluid and peripheral blood of women with early- and late-staged endometriosis. Arch Gynecol Obstet. 2009;279:891–895.
- Wickiewicz D, Chrobak A, Gmyrek GB, et al. Diagnostic accuracy of interleukin-6 levels in peritoneal fluid for detection of endometriosis. Arch Gynecol Obstet. 2013;288:805–814.
- Martinez S, Garrido N, Coperias JL, et al. Serum interleukin-6 levels are elevated in women with minimal-mild endometriosis. Hum Reprod. 2007; 22:836–842.
- Jee BC, Suh CS, Kim SH, Moon SY. Serum soluble CD163 and interleukin-6 levels in women with ovarian endometriomas. Gynecol Obstet Invest. 2008;66:47–52.
- Seeber B, Sammel MD, Fan X, et al. Proteomic analysis of serum yields six candidate proteins that are differentially regulated in a subset of women with endometriosis. Fertil Steril. 2010;93:2137–2144.
- Kaabachi W, Kacem O, Belhaj R, et al. Interleukin-37 in endometriosis. Immunol Lett. 2017;185:52–55.